Intermede Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$77.4M |
| 2 |
DexCom
DXCM
|
+$58.8M |
| 3 |
Intuit
INTU
|
+$50.8M |
| 4 |
Waste Management
WM
|
+$50M |
| 5 |
Linde
LIN
|
+$26.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MSCI
MSCI
|
+$65M |
| 2 |
Cooper Companies
COO
|
+$62.9M |
| 3 |
Salesforce
CRM
|
+$58.5M |
| 4 |
Applied Materials
AMAT
|
+$22.1M |
| 5 |
Danaher
DHR
|
+$19.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.61% |
| 2 | Financials | 18.83% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Communication Services | 11.51% |
| 5 | Industrials | 9.95% |
Similar funds
Intermede Investment Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Intermede Investment Partners held 35 positions worth $2.43B, up 0.02% from $2.43B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Intermede Investment Partners withdrew a net $73.7M in Q4 2025, closing 4 positions and reducing 21 holdings. Its most notable exit was MSCI, an estimated $65M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Intermede Investment Partners opened a new position in CME Group worth $77.8M.
- Intermede Investment Partners's largest Q4 2025 buy was CME Group: 284,959 shares worth $77.8M.
- Intermede Investment Partners added most to Linde in Q4 2025, an estimated $26.2M increase.
- Intermede Investment Partners's biggest Q4 2025 reduction was Applied Materials, cutting an estimated $22.1M.
- Intermede Investment Partners fully exited MSCI in Q4 2025, selling an estimated $65M.
- Intermede Investment Partners's ten largest holdings make up 53% of its $2.43B portfolio in Q4 2025.
- Intermede Investment Partners opened 4 new positions and closed 4 in Q4 2025.
- Intermede Investment Partners's portfolio value rose 0.02% quarter-over-quarter to $2.43B.
Based on Intermede Investment Partners's 13F filing for Q4 2025, filed 9 Feb 2026.